Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Public ClinicalTrials.gov record NCT06948955. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this expanded access program (EAP) is to provide investigational bezuclastinib so that it can be coadministered with sunitinib to patients with a diagnosis of gastrointestinal stromal tumors (GIST) with no comparable or satisfactory alternative therapy options. The combination of bezuclastinib and sunitinib provides broad inhibition of all primary and secondary KIT mutations that commonly occur in GIST.
Study identification
- NCT ID
- NCT06948955
- Recruitment status
- Available
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jul 12, 2026
United States locations
- U.S. sites
- 25
- U.S. states
- 18
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | Available |
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Available |
| UCLA Department of Medicine- Hematology/Oncology | Los Angeles | California | 90095 | Available |
| University of Colorado | Aurora | Colorado | 80045 | Available |
| Smillow Cancer Hospital - Yale New Haven Health | New Haven | Connecticut | 06510 | Available |
| Mayo Clinic | Jacksonville | Florida | 32224 | Available |
| Orlando Health | Orlando | Florida | 32806 | Available |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | Available |
| The University of Chicago Medical Center | Chicago | Illinois | 60637 | Available |
| Johns Hopkins University | Baltimore | Maryland | 21287 | Available |
| Dana Farber Cancer Institute (DFCI) | Boston | Massachusetts | 02215 | Available |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | Available |
| Mayo Clinic | Rochester | Minnesota | 55905 | Available |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | Available |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | Available |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | Available |
| The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | Available |
| Taylor Cancer Research Center | Maumee | Ohio | 43537 | Available |
| Oregon Health and Sciences University | Portland | Oregon | 97239 | Available |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | Available |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | Available |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Available |
| Huntsman Cancer Institute, University of Utah | Salt Lake City | Utah | 84112 | Available |
| Shenandoah Oncology | Winchester | Virginia | 22601 | Available |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | Available |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06948955, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06948955 live on ClinicalTrials.gov.